Comorbidities and their impact on chronic obstructive pulmonary disease
| Autor: | Dursunoğlu, Neşe., Köktürk, N., Baha, A., Bilge, A.K., Börekçi, Ş., Çiftçi, F., Karadağ, M.G., Kütükçü, E.Ç., Noyan, A., Polatli, M., Önen, Z.P., Sarinç, S., Umut, S., Uzaslan, E., Üzüm, A.K., Yildiz, Ö.A., Turkish Thoracic Society-COPD Comorbidity Group |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
obesity
interleukin 1beta Lung Neoplasms Health Status gastroesophageal reflux heart failure vitamin D Comorbidity lung tumor Pulmonary Disease Chronic Obstructive cardiovascular disease Musculoskeletal Diseases megestrol sleep disorder family history C reactive protein Disease Management clinical trial (topic) anxiety anemia emphysema Cardiovascular Diseases ghrelin depression diabetes mellitus parathyroid hormone[1-34] lung diffusion capacity hypertension tumor necrosis factor vitamin D deficiency interleukin 6 complication malnutrition Article smoking mental disorders COPD Humans human calcium aging lung fibrosis denosumab asthma ischemic heart disease osteoporosis body mass respiratory system respiratory tract diseases lung cancer quality of life growth hormone testosterone fibrinogen metabolic syndrome X chronic obstructive lung disease musculoskeletal disease |
| Popis: | Chronic obstructive pulmonary disease (COPD) is a complex disease that is associated with devastating outcomes resulting from lung involvement and several comorbidities. Comorbidities could impact on symptomology, quality of life, the complications, the management, economic burden and the mortality of the disease. The importance of comorbidities originates from their impact on the outcome of COPD. The most frequent comorbidities in COPD are cardiovascular, endocrinological, musculoskeletal, phycological disorders and lung cancer. Almost 50% of the COPD patients have 3 or more comorbidities. The recent Global Initiative of Obstructive Lung Disease (GOLD) Guideline suggested proactive search and the treatment of the comorbidities. However, there is no certain evidence demonstrating that active treatment of comorbidities improve the outcomes of COPD. However, it is well known that several comorbidities such as cardiovascular disease and lung cancer have greater impact on mortality caused by COPD. Several studies have shown that Charlson Comorbidity index or more recenty COPD Specific Comorbidity Index (COTE) has been found to be related with mortality of COPD. This concise review intended to summarize the most frequent comorbidities in association with their impact on COPD. © 2016, Ankara University. All rights reserved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|